A phase I dose escalation study of LBQ707 (gimatecan) administered orally twice per week to Japanese patients with advanced solid tumors
Phase of Trial: Phase I
Latest Information Update: 22 Jul 2008
At a glance
- Drugs Gimatecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jul 2008 Status changed from recruiting to completed, from clinicaltrials.gov record.
- 12 Jul 2007 New trial record.